Drugs in MeSH Category Phosphodiesterase 5 Inhibitors
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accord Hlthcare | TADALAFIL | tadalafil | TABLET;ORAL | 209167-003 | Oct 23, 2019 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Austarpharma | TADALAFIL | tadalafil | TABLET;ORAL | 208824-002 | Oct 27, 2020 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 212051-001 | Mar 22, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Reyoung | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 208494-003 | Jun 12, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |